129 related articles for article (PubMed ID: 37964338)
1. Cough and sputum in long COVID are associated with severe acute COVID-19: a Japanese cohort study.
Watase M; Miyata J; Terai H; Sunata K; Matsuyama E; Asakura T; Namkoong H; Masaki K; Yagi K; Ohgino K; Chubachi S; Kawada I; Mochimaru T; Satomi R; Oyamada Y; Kobayashi K; Hirano T; Inoue T; Lee H; Sugihara K; Omori N; Sayama K; Mashimo S; Makino Y; Kaido T; Ishii M; Fukunaga K
Respir Res; 2023 Nov; 24(1):283. PubMed ID: 37964338
[TBL] [Abstract][Full Text] [Related]
2. Asthma is a risk factor for general fatigue of long COVID in Japanese nation-wide cohort study.
Sunata K; Miyata J; Terai H; Matsuyama E; Watase M; Namkoong H; Asakura T; Masaki K; Chubachi S; Ohgino K; Kawada I; Harada N; Sasano H; Nakamura A; Kusaka Y; Ohba T; Nakano Y; Nishio K; Nakajima Y; Suzuki S; Yoshida S; Tateno H; Ishii M; Fukunaga K
Allergol Int; 2024 Apr; 73(2):206-213. PubMed ID: 37996384
[TBL] [Abstract][Full Text] [Related]
3. A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial.
Takayama S; Namiki T; Ito T; Arita R; Nakae H; Kobayashi S; Yoshino T; Ishigami T; Tanaka K; Kainuma M; Nochioka K; Takagi A; Mimura M; Yamaguchi T; Ishii T
Trials; 2020 Oct; 21(1):827. PubMed ID: 33008479
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of long COVID in a Japanese nationwide prospective cohort study.
Terai H; Ishii M; Takemura R; Namkoong H; Shimamoto K; Masaki K; Tanosaki T; Chubachi S; Matsuyama E; Hayashi R; Shimada T; Shigematsu L; Ito F; Kaji M; Takaoka H; Kurihara M; Nakagawara K; Tomiyasu S; Sasahara K; Saito A; Otake S; Azekawa S; Okada M; Fukushima T; Morita A; Tanaka H; Sunata K; Asaoka M; Nishie M; Shinozaki T; Ebisudani T; Akiyama Y; Mitsuishi A; Nakayama S; Ogawa T; Sakurai K; Irie M; Yagi K; Ohgino K; Miyata J; Kabata H; Ikemura S; Kamata H; Yasuda H; Kawada I; Kimura R; Kondo M; Iwasaki T; Ishida N; Hiruma G; Miyazaki N; Ishibashi Y; Harada S; Fujita T; Ito D; Bun S; Tabuchi H; Kanzaki S; Shimizu E; Fukuda K; Yamagami J; Kobayashi K; Hirano T; Inoue T; Haraguchi M; Kagyo J; Shiomi T; Lee H; Sugihara K; Omori N; Sayama K; Otsuka K; Miyao N; Odani T; Watase M; Mochimaru T; Satomi R; Oyamada Y; Masuzawa K; Asakura T; Nakayama S; Suzuki Y; Baba R; Okamori S; Arai D; Nakachi I; Kuwahara N; Fujiwara A; Oakada T; Ishiguro T; Isosno T; Makino Y; Mashimo S; Kaido T; Minematsu N; Ueda S; Minami K; Hagiwara R; Manabe T; Fukui T; Funatsu Y; Koh H; Yoshiyama T; Kokuto H; Kusumoto T; Oashi A; Miyawaki M; Saito F; Tani T; Ishioka K; Takahashi S; Nakamura M; Harada N; Sasano H; Goto A; Kusaka Y; Ohba T; Nakano Y; Nishio K; Nakajima Y; Suzuki S; Yoshida S; Tateno H; Kodama N; Shunsuke M; Sakamoto S; Okamoto M; Nagasaki Y; Umeda A; Miyagawa K; Shimada H; Hagimura K; Nagashima K; Sato T; Sato Y; Hasegawa N; Takebayashi T; Nakahara J; Mimura M; Ogawa K; Shimmura S; Negishi K; Tsubota K; Amagai M; Goto R; Ibuka Y; Kitagawa Y; Kanai T; Fukunaga K
Respir Investig; 2023 Nov; 61(6):802-814. PubMed ID: 37783167
[TBL] [Abstract][Full Text] [Related]
5. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
6. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
7. Differences of Severe Acute Respiratory Syndrome Coronavirus 2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens Among Adult Inpatients With Coronavirus Disease 2019.
Wang K; Zhang X; Sun J; Ye J; Wang F; Hua J; Zhang H; Shi T; Li Q; Wu X
Chest; 2020 Nov; 158(5):1876-1884. PubMed ID: 32569635
[TBL] [Abstract][Full Text] [Related]
8. Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.
Jeong TH; Pak C; Ock M; Lee SH; Son JS; Jeon YJ
J Korean Med Sci; 2020 Sep; 35(37):e333. PubMed ID: 32959547
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and risk factors for postinfectious cough in discharged patients with coronavirus disease 2019 (COVID-19).
Chen Y; Zhang X; Zeng X; Xu T; Xiao W; Yang X; Zhan W; Zhan C; Lai K
J Thorac Dis; 2022 Jun; 14(6):2079-2088. PubMed ID: 35813767
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Post-COVID-19 Cough One Year After SARS-CoV-2 Infection: A Multicenter Study.
Fernández-de-Las-Peñas C; Guijarro C; Plaza-Canteli S; Hernández-Barrera V; Torres-Macho J
Lung; 2021 Jun; 199(3):249-253. PubMed ID: 33993321
[TBL] [Abstract][Full Text] [Related]
11. Post-Acute COVID-19 Respiratory Symptoms in Patients With Asthma: An Electronic Health Records-Based Study.
Wang L; Foer D; Zhang Y; Karlson EW; Bates DW; Zhou L
J Allergy Clin Immunol Pract; 2023 Mar; 11(3):825-835.e3. PubMed ID: 36566779
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with a SARS-CoV-2 recurrence after hospital discharge among patients with COVID-19: systematic review and meta-analysis.
Yao MQ; Zheng QX; Xu J; Deng JW; Ge TT; Zhou HB; Wu FT; Gu XY; Yang Q; Ren YL; Wang G; Chen Z
J Zhejiang Univ Sci B; 2020 Dec.; 21(12):940-947. PubMed ID: 33843159
[TBL] [Abstract][Full Text] [Related]
13. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
Huang C; Huang L; Wang Y; Li X; Ren L; Gu X; Kang L; Guo L; Liu M; Zhou X; Luo J; Huang Z; Tu S; Zhao Y; Chen L; Xu D; Li Y; Li C; Peng L; Li Y; Xie W; Cui D; Shang L; Fan G; Xu J; Wang G; Wang Y; Zhong J; Wang C; Wang J; Zhang D; Cao B
Lancet; 2021 Jan; 397(10270):220-232. PubMed ID: 33428867
[TBL] [Abstract][Full Text] [Related]
14. Long-COVID Clinical Features and Risk Factors: A Retrospective Analysis of Patients from the STOP-COVID Registry of the PoLoCOV Study.
Chudzik M; Babicki M; Kapusta J; Kałuzińska-Kołat Ż; Kołat D; Jankowski P; Mastalerz-Migas A
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016376
[TBL] [Abstract][Full Text] [Related]
15. Cluster analysis of long COVID in Japan and association of its trajectory of symptoms and quality of life.
Ito F; Terai H; Kondo M; Takemura R; Namkoong H; Asakura T; Chubachi S; Masuzawa K; Nakayama S; Suzuki Y; Hashiguchi M; Kagyo J; Shiomi T; Minematsu N; Manabe T; Fukui T; Funatsu Y; Koh H; Masaki K; Ohgino K; Miyata J; Kawada I; Ishii M; Sato Y; Fukunaga K
BMJ Open Respir Res; 2024 Feb; 11(1):. PubMed ID: 38395459
[TBL] [Abstract][Full Text] [Related]
16. Persistent cough and asthma-like symptoms post COVID-19 hospitalization in children.
Esmaeilzadeh H; Sanaei Dashti A; Mortazavi N; Fatemian H; Vali M
BMC Infect Dis; 2022 Mar; 22(1):244. PubMed ID: 35279094
[TBL] [Abstract][Full Text] [Related]
17. A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study).
Namiki T; Takayama S; Arita R; Ishii T; Kainuma M; Makino T; Mimura M; Yoshino T; Nogami T; Arai M; Sato J; Tanaka K; Nakae H; Igari H; Ozawa Y; Shiko Y; Kawasaki Y; Nezu M; Ito T
Trials; 2021 Jan; 22(1):23. PubMed ID: 33407828
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
19. High body mass index is a significant risk factor for the progression and prognosis of imported COVID-19: a multicenter, retrospective cohort study.
Cai H; Yang L; Lu Y; Zhang S; Ye C; Zhang X; Yu G; Gu J; Lian J; Hao S; Hu J; Zhang Y; Jin C; Sheng J; Yang Y; Jia H
BMC Infect Dis; 2021 Feb; 21(1):147. PubMed ID: 33546633
[TBL] [Abstract][Full Text] [Related]
20. Post-Discharge Symptoms among Hospitalized COVID-19 Patients in Nigeria: A Single-Center Study.
Ogoina D; James HI; Ogoinja SZ
Am J Trop Med Hyg; 2021 Jul; 105(3):731-736. PubMed ID: 34270448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
